Akoya to Participate at Three Upcoming Investor Conferences - November 03, 2022
MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in three upcoming investor conferences.
- Stephens Annual Investment Conference (Nashville, TN)
Fireside Chat on Wednesday, November 16th at 2:00 PM CT
- Canaccord Genuity Annual MedTech, Diagnostics and Digital Health & Services Forum (New York, NY)
Multi-omics Panel on Thursday, November 17th at 1:00 PM ET
- Piper-Sandler Annual Healthcare Conference (New York, NY)
Fireside Chat on Thursday, December 1st at 11:30 AM ET
Live and archived webcasts of the events will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Sr. Director, Investor Relations
Akoya Biosciences, Inc.